What is he best known for?
The fields of study he is best known for:
Jo Van Damme mainly focuses on Molecular biology, Immunology, Chemokine, CC chemokine receptors and Chemotaxis.
His research in Molecular biology intersects with topics in Endocrinology, Internal medicine, Interleukin, CCL7 and Chemokine receptor CCR5.
His Immunology research is multidisciplinary, incorporating perspectives in Cancer research, Neuroscience and Cell biology.
As part of the same scientific family, he usually focuses on Chemokine, concentrating on Dipeptidyl peptidase and intersecting with CXC chemokine receptors.
His studies in CC chemokine receptors integrate themes in fields like CXCL2, CCL13, CCL15, CCL21 and C-C chemokine receptor type 6.
As part of his studies on Chemotaxis, Jo Van Damme frequently links adjacent subjects like Interleukin 8.
His most cited work include:
- The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (1037 citations)
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 (524 citations)
- Macrophage inflammatory protein-1 (513 citations)
What are the main themes of his work throughout his whole career to date?
Jo Van Damme mostly deals with Molecular biology, Chemokine, Biochemistry, Immunology and Chemotaxis.
His Molecular biology research includes themes of Cell culture, CXCL2, Interleukin 8, Granulocyte and Monocyte.
His CXCL2 research also works with subjects such as
- CCL15 and related CCL23, CC chemokine receptors and CCL20,
- CCL21 and related C-C chemokine receptor type 6,
- CCL7 and related CCR1.
His Chemokine research incorporates elements of Citrullination, In vivo and Cell biology.
His study focuses on the intersection of Immunology and fields such as Cancer research with connections in the field of Platelet factor 4.
His work in Chemotaxis covers topics such as CXC chemokine receptors which are related to areas like CXCL14.
He most often published in these fields:
- Molecular biology (39.66%)
- Chemokine (34.91%)
- Biochemistry (31.03%)
What were the highlights of his more recent work (between 2011-2021)?
- Chemokine (34.91%)
- Immunology (28.02%)
- Cell biology (12.50%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Chemokine, Immunology, Cell biology, Inflammation and Chemotaxis.
His Chemokine research entails a greater understanding of Biochemistry.
The concepts of his Biochemistry study are interwoven with issues in Interleukin 8 and Pharmacology.
His Cell biology study combines topics in areas such as Monocyte chemoattractant protein and CXCR4.
His Chemotaxis study integrates concerns from other disciplines, such as Serum amyloid A1, Signal transduction, CXC chemokine receptors and Monocyte.
Within one scientific family, Jo Van Damme focuses on topics pertaining to Molecular biology under Peptide, and may sometimes address concerns connected to Chemokine receptor.
Between 2011 and 2021, his most popular works were:
- Regulation of TNF-α with a focus on rheumatoid arthritis. (99 citations)
- Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults. (78 citations)
- Chemokine-Induced Macrophage Polarization in Inflammatory Conditions. (75 citations)
In his most recent research, the most cited papers focused on:
Jo Van Damme spends much of his time researching Immunology, Chemokine, Cell biology, Biochemistry and Inflammation.
His Chemokine research is multidisciplinary, incorporating elements of Microbiology, Chemotaxis, In vivo and Leukocyte migration.
In his work, Molecular biology is strongly intertwined with Lymphocyte chemotaxis, which is a subfield of Leukocyte migration.
Jo Van Damme has researched Cell biology in several fields, including Chemokine activity, CXCL9, CXCL2 and CCR1.
His work in Biochemistry tackles topics such as Interleukin 8 which are related to areas like Neutrophil extravasation and Peptide.
His study looks at the relationship between Cytokine and topics such as Tumor necrosis factor alpha, which overlap with CCL2.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
